99% Savings - Buy Just @1 Rs X
Panfast Dsr is a prescription drug, available for use as Capsule. The alternative uses of Panfast Dsr have also been explained below.
The optimal dosage of Panfast Dsr is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Panfast Dsr include Headache, Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Panfast Dsr as well, which are listed below. Usually, these side effects of Panfast Dsr go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Panfast Dsr's effect during pregnancy is Severe and Severe while nursing. Further, the section on Panfast Dsr related warnings talks about Panfast Dsr's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Osteoporosis, Kidney Disease must refrain from the use of Panfast Dsr since this can cause severe adverse effects.
Besides this, Panfast Dsr may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Panfast Dsr is not safe while driving, and is is not addictive in nature.
Panfast Dsr is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Panfast Dsr safe for pregnant women?
Panfast Dsr has many dangerous side effects in pregnant women. If you are pregnant, do not consume Panfast Dsr without medical advice.
Is the use of Panfast Dsr safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Panfast Dsr. So it is adviced to consult the doctor before using it.
What is the effect of Panfast Dsr on the Kidneys?
Panfast Dsr can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Panfast Dsr on the Liver?
You may experience side effects on your liver after taking Panfast Dsr. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Panfast Dsr on the Heart?
Side effects of Panfast Dsr rarely affect the heart.
Panfast Dsr should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Panfast Dsr unless your doctor advises you to do so -
Is this Panfast Dsr habit forming or addictive?
Forming a habit of Panfast Dsr has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Panfast Dsr you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Panfast Dsr is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Panfast Dsr is not used to treat mental disorders.
Interaction between Food and Panfast Dsr
Due to the absence of research, it is difficult to say how Panfast Dsr and food will interact.
Interaction between Alcohol and Panfast Dsr
Information about the interaction of Panfast Dsr and alcohol is not currently available because this topic has not been researched yet.
Panfast Dsr contains domperidone (dopamine D2-receptor antagonist). It works by inhibiting the neurotransmitter dopamine (a chemical messenger present in our body) from acting on the vomiting center present in the brain thus preventing nausea and vomiting which provides relief to the patient from nausea and vomiting.
Yes, Panfast Dsr has been reported to cause diarrhoea but this occurs in a few cases only. It is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhoea after taking this drug, discuss your doctor immediately without any further delay.
Ideally, Panfast Dsr should be taken by mouth once daily but it can be taken twice in some cases depending on the severity of symptoms or as advised by your doctor. It should be taken before 30 minutes of eating food to prevent acidity and heartburn. Precautions must be taken in patients with hypersensitivity and improper liver function.
Panfast Dsr is a brand name for domperidone. It is a prescription drug which belongs to the class of medication known as antiemetics (dopamine D2-receptor antagonist). It is mainly used for the treatment of nausea, vomiting, bloating and stomach fullness. It is also used to prevent nausea and vomiting caused by certain medication used to treat Parkinson's disease.
Yes, Panfast Dsr can cause dry mouth. It is a rare side effect of this drug. If you experience severe dry mouth after taking this drug, keep yourself hydrated with juices, shakes, and ample water.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Protonix (pantoprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 984-986